
Meiya Li
Examiner (ID: 12082, Phone: (571)270-1572 , Office: P/2811 )
| Most Active Art Unit | 2811 |
| Art Unit(s) | 2811 |
| Total Applications | 1080 |
| Issued Applications | 665 |
| Pending Applications | 104 |
| Abandoned Applications | 330 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20639906
[patent_doc_number] => 20260098259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-04-09
[patent_title] => TREATING AND PREVENTING MICROBIAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 19/367025
[patent_app_country] => US
[patent_app_date] => 2025-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48907
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19367025
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/367025 | TREATING AND PREVENTING MICROBIAL INFECTIONS | Oct 22, 2025 | Pending |
Array
(
[id] => 19707843
[patent_doc_number] => 20250017985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-16
[patent_title] => BACILLUS VELEZENSIS COMPOSITIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/768920
[patent_app_country] => US
[patent_app_date] => 2024-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15055
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18768920
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/768920 | Bacillus velezensis compositions and methods of use thereof | Jul 9, 2024 | Issued |
Array
(
[id] => 19498636
[patent_doc_number] => 20240337654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-10
[patent_title] => METHOD FOR LATERAL FLOW IMMUNOASSAY
[patent_app_type] => utility
[patent_app_number] => 18/749553
[patent_app_country] => US
[patent_app_date] => 2024-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5892
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18749553
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/749553 | METHOD FOR LATERAL FLOW IMMUNOASSAY | Jun 19, 2024 | Pending |
Array
(
[id] => 19856568
[patent_doc_number] => 12259396
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-25
[patent_title] => Methods and compositions for assessing antibody specificities
[patent_app_type] => utility
[patent_app_number] => 18/744293
[patent_app_country] => US
[patent_app_date] => 2024-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 28
[patent_no_of_words] => 35385
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18744293
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/744293 | Methods and compositions for assessing antibody specificities | Jun 13, 2024 | Issued |
Array
(
[id] => 19447402
[patent_doc_number] => 20240307532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => Synergistic Inhibition of eIF5A and Notch Signaling in Intermediate Tregs
[patent_app_type] => utility
[patent_app_number] => 18/670112
[patent_app_country] => US
[patent_app_date] => 2024-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23368
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18670112
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/670112 | Synergistic Inhibition of eIF5A and Notch Signaling in Intermediate Tregs | May 20, 2024 | Pending |
Array
(
[id] => 19417353
[patent_doc_number] => 20240293476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => Methods and Compositions for Changing Metabolite Levels in a Subject
[patent_app_type] => utility
[patent_app_number] => 18/652238
[patent_app_country] => US
[patent_app_date] => 2024-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43580
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18652238
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/652238 | Methods and Compositions for Changing Metabolite Levels in a Subject | Apr 30, 2024 | Pending |
Array
(
[id] => 19389762
[patent_doc_number] => 20240279632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => SUBTILISIN VARIANTS HAVING IMPROVED STABILITY
[patent_app_type] => utility
[patent_app_number] => 18/640088
[patent_app_country] => US
[patent_app_date] => 2024-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37218
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18640088
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/640088 | SUBTILISIN VARIANTS HAVING IMPROVED STABILITY | Apr 18, 2024 | Pending |
Array
(
[id] => 19402186
[patent_doc_number] => 20240285697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => Method and System to Modify an Individual's Gut-Brain Axis to Provide Neurocognitive Protection
[patent_app_type] => utility
[patent_app_number] => 18/620483
[patent_app_country] => US
[patent_app_date] => 2024-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19655
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18620483
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/620483 | Method and system to modify an individual's gut-brain axis to provide neurocognitive protection | Mar 27, 2024 | Issued |
Array
(
[id] => 19387910
[patent_doc_number] => 20240277780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => Modulation of an Individual's Gut Microbiome to Address Osteoporosis and Bone Disease
[patent_app_type] => utility
[patent_app_number] => 18/615672
[patent_app_country] => US
[patent_app_date] => 2024-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17494
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18615672
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/615672 | Modulation of an individual's gut microbiome to address osteoporosis and bone disease | Mar 24, 2024 | Issued |
Array
(
[id] => 19318595
[patent_doc_number] => 20240240138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => ANTI-PHYTOPATHOGENIC COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/594880
[patent_app_country] => US
[patent_app_date] => 2024-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17884
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18594880
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/594880 | ANTI-PHYTOPATHOGENIC COMPOSITIONS | Mar 3, 2024 | Pending |
Array
(
[id] => 19684330
[patent_doc_number] => 20250002875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-02
[patent_title] => COMPOSITIONS AND METHODS RELATING TO A MUTANT CLOSTRIDIUM DIFFICILE TOXIN
[patent_app_type] => utility
[patent_app_number] => 18/593348
[patent_app_country] => US
[patent_app_date] => 2024-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67106
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18593348
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/593348 | COMPOSITIONS AND METHODS RELATING TO A MUTANT CLOSTRIDIUM DIFFICILE TOXIN | Feb 29, 2024 | Pending |
Array
(
[id] => 19477470
[patent_doc_number] => 20240325512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => VACCINE FOR PROTECTION AGAINST ETEC-INDUCED DIARRHEA COMPRISING DMLT
[patent_app_type] => utility
[patent_app_number] => 18/590696
[patent_app_country] => US
[patent_app_date] => 2024-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7296
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18590696
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/590696 | VACCINE FOR PROTECTION AGAINST ETEC-INDUCED DIARRHEA COMPRISING DMLT | Feb 27, 2024 | Pending |
Array
(
[id] => 19201461
[patent_doc_number] => 20240173360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING EPILEPSY AND RELATED DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/425385
[patent_app_country] => US
[patent_app_date] => 2024-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23402
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18425385
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/425385 | COMPOSITIONS AND METHODS FOR TREATING EPILEPSY AND RELATED DISORDERS | Jan 28, 2024 | Pending |
Array
(
[id] => 19417350
[patent_doc_number] => 20240293473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => METHODS FOR DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES
[patent_app_type] => utility
[patent_app_number] => 18/424075
[patent_app_country] => US
[patent_app_date] => 2024-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35262
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18424075
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/424075 | METHODS FOR DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES | Jan 25, 2024 | Pending |
Array
(
[id] => 19156140
[patent_doc_number] => 20240148847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => EDIBLE VACCINATION AGAINST MICROBIAL PATHOGENS
[patent_app_type] => utility
[patent_app_number] => 18/414392
[patent_app_country] => US
[patent_app_date] => 2024-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10896
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18414392
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/414392 | EDIBLE VACCINATION AGAINST MICROBIAL PATHOGENS | Jan 15, 2024 | Pending |
Array
(
[id] => 20756223
[patent_doc_number] => 12648972
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-09
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 18/413001
[patent_app_country] => US
[patent_app_date] => 2024-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 16
[patent_no_of_words] => 8627
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18413001
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/413001 | None | Jan 14, 2024 | Issued |
Array
(
[id] => 19387954
[patent_doc_number] => 20240277824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => BIOCONJUGATES MADE FROM RECOMBINANT N-GLYCOSYLATED PROTEINS FROM PROCARYOTIC CELLS
[patent_app_type] => utility
[patent_app_number] => 18/402174
[patent_app_country] => US
[patent_app_date] => 2024-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17936
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18402174
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/402174 | BIOCONJUGATES MADE FROM RECOMBINANT N-GLYCOSYLATED PROTEINS FROM PROCARYOTIC CELLS | Jan 1, 2024 | Pending |
Array
(
[id] => 20453245
[patent_doc_number] => 12516297
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-06
[patent_title] => Propagator cells and methods for propagating phage, in particular for delivering CRISPR-Cas components via probiotic organisms
[patent_app_type] => utility
[patent_app_number] => 18/539066
[patent_app_country] => US
[patent_app_date] => 2023-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 19230
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18539066
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/539066 | Propagator cells and methods for propagating phage, in particular for delivering CRISPR-Cas components via probiotic organisms | Dec 12, 2023 | Issued |
Array
(
[id] => 19112790
[patent_doc_number] => 20240124540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => IMMUNOGENIC COMPOSITIONS TARGETING RECURRENT CANCER MUTATIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/516360
[patent_app_country] => US
[patent_app_date] => 2023-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 128180
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18516360
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/516360 | IMMUNOGENIC COMPOSITIONS TARGETING RECURRENT CANCER MUTATIONS AND METHODS OF USE THEREOF | Nov 20, 2023 | Abandoned |
Array
(
[id] => 20357350
[patent_doc_number] => 12473333
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-18
[patent_title] => Method for increasing ETEC CS6 antigen presentation on cell surface and products obtainable thereof
[patent_app_type] => utility
[patent_app_number] => 18/509081
[patent_app_country] => US
[patent_app_date] => 2023-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 1123
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18509081
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/509081 | Method for increasing ETEC CS6 antigen presentation on cell surface and products obtainable thereof | Nov 13, 2023 | Issued |